14.36MMarket Cap-5650P/E (TTM)
2.540High2.482Low5.23KVolume2.540Open2.540Pre Close13.10KTurnover0.11%Turnover RatioLossP/E (Static)5.70MShares5.96052wk High1.25P/B11.88MFloat Cap1.48152wk Low--Dividend TTM4.71MShs Float28.990Historical High--Div YieldTTM2.30%Amplitude1.390Historical Low2.504Avg Price1Lot Size
Immuron Stock Forum
Australian Medical Company Reports Positive Results For Gut-mediated Diseases
Immuron Limited (NASDAQ: IMRN), an Australian biopharmaceutical company, has recently announced positive results that support the progress of its flagship product, Travelan®, into Phase 3 Clinical Trials in the United States. This significant development could potentially have far-reaching impacts on the global pharmaceutical landscape. $Immuron(IMRN.US)$
...
Extremely happy anyways! 🦘🦘
All lvl’ Broke baby!
WoooHoooo
Amazingly confusing! Hehehe!
Hehehe
Hope yall won
No comment yet